Christopher J. Schultz

14.3k total citations · 4 hit papers
138 papers, 8.7k citations indexed

About

Christopher J. Schultz is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Radiation. According to data from OpenAlex, Christopher J. Schultz has authored 138 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 43 papers in Genetics and 39 papers in Radiation. Recurrent topics in Christopher J. Schultz's work include Glioma Diagnosis and Treatment (43 papers), Advanced Radiotherapy Techniques (39 papers) and Head and Neck Cancer Studies (35 papers). Christopher J. Schultz is often cited by papers focused on Glioma Diagnosis and Treatment (43 papers), Advanced Radiotherapy Techniques (39 papers) and Head and Neck Cancer Studies (35 papers). Christopher J. Schultz collaborates with scholars based in United States, Canada and China. Christopher J. Schultz's co-authors include Bruce H. Campbell, Minesh P. Mehta, Mitchell Machtay, Anthony J. Cmelak, Jay S. Cooper, Arlene A. Forastiere, Harold E. Kim, Julie A. Kish, Scott Saxman and Thomas F. Pajak and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Christopher J. Schultz

130 papers receiving 8.5k citations

Hit Papers

Postoperative Concurrent ... 2002 2026 2010 2018 2004 2013 2002 2012 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
    2004 2.3k citations Arlene A. Forastiere, Bruce H. Campbell et al. profile →
  2. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
    2013 742 citations Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology profile →
  3. Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10
    2002 522 citations Barbara Fisher, Christopher J. Schultz et al. Journal of Clinical Oncology profile →
  4. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
    2012 385 citations Arlene A. Forastiere, Marvin Rotman et al. International Journal of Radiation Oncology*Biology*Physics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher J. Schultz 3.1k 3.0k 3.0k 2.4k 2.0k 138 8.7k
Suzanne L. Wolden 3.1k 1.0× 5.2k 1.7× 1.0k 0.3× 3.6k 1.5× 3.1k 1.6× 348 11.4k
Simon Krämer 958 0.3× 3.4k 1.1× 2.2k 0.7× 1.8k 0.7× 2.0k 1.0× 154 7.2k
Shiao Y. Woo 527 0.2× 3.3k 1.1× 2.4k 0.8× 1.5k 0.6× 1.2k 0.6× 175 7.3k
Tejpal Gupta 1.6k 0.5× 1.7k 0.6× 1.3k 0.4× 1.2k 0.5× 879 0.4× 300 4.5k
Luther W. Brady 789 0.3× 4.4k 1.5× 1.2k 0.4× 2.1k 0.9× 2.9k 1.5× 342 10.1k
Gerhard G. Grabenbauer 1.2k 0.4× 2.0k 0.7× 930 0.3× 2.7k 1.1× 3.1k 1.6× 179 6.8k
William F. Regine 402 0.1× 5.2k 1.7× 2.6k 0.9× 3.5k 1.4× 4.6k 2.4× 241 10.7k
Nancy P. Mendenhall 464 0.1× 3.5k 1.2× 747 0.3× 1.7k 0.7× 2.8k 1.4× 357 8.5k
Marvin Rotman 2.2k 0.7× 4.4k 1.5× 2.4k 0.8× 2.3k 0.9× 2.8k 1.4× 67 7.6k
Zhigang Zhang 670 0.2× 4.1k 1.4× 902 0.3× 1.4k 0.6× 1.8k 0.9× 169 6.7k

Countries citing papers authored by Christopher J. Schultz

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Schultz more than expected).

Fields of papers citing papers by Christopher J. Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Schultz. The network helps show where Christopher J. Schultz may publish in the future.

Co-authorship network of co-authors of Christopher J. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Schultz. A scholar is included among the top collaborators of Christopher J. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Schultz. Christopher J. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schultz, Christopher J. & Michael Smith. (2024). Enhanced IoT Water Quality Monitoring System for Data-Based Aquaculture. 329–334. 1 indexed citations
2.
Hall, William A., Angela Mathison, Michael Tschannen, et al.. (2024). Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations. International Journal of Radiation Oncology*Biology*Physics. 120(2). 570–578.
3.
Mora, Javier, Michael Straza, Bradley A. Erickson, et al.. (2023). Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Advances in Radiation Oncology. 8(4). 101206–101206. 2 indexed citations
4.
Divi, Vasu, Becky Massey, Bruce H. Campbell, et al.. (2019). Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer. Oral Oncology. 98. 125–131. 27 indexed citations
5.
Nguyen, Ha Son, Elizabeth J. Cochran, Jennifer Connelly, et al.. (2016). Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. American Journal of Neuroradiology. 37(12). 2201–2208. 56 indexed citations
6.
Vassilakopoulou, Maria, Minhee Won, W.J. Curran, et al.. (2015). BRCA1 Protein Expression Predicts Survival in Glioblastoma Multiforme (GBM) Patients From a RTOG Cohort. International Journal of Radiation Oncology*Biology*Physics. 93(3). S141–S141. 1 indexed citations
7.
Feng, Mei, Xiaojian Chen, Shouping Xu, et al.. (2015). Computed Tomography Number Changes Observed During Computed Tomography–Guided Radiation Therapy for Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 91(5). 1041–1047. 21 indexed citations
8.
Gilbert, Mark R., Meihua Wang, Kenneth Aldape, et al.. (2013). Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial. Journal of Clinical Oncology. 31(32). 4085–4091. 742 indexed citations breakdown →
9.
Krauze, Andra, Minhee Won, B. Corn, et al.. (2013). Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM). Biomarker Research. 1(1). 29–29. 5 indexed citations
10.
Liu, Feng, E Ahunbay, C.A. Lawton, et al.. (2013). Combined online and offline adaptive radiation therapy: A dosimetric feasibility study. Practical Radiation Oncology. 4(1). e75–e83. 11 indexed citations
11.
Michel, Michelle A., Christopher J. Schultz, Mohit Maheshwari, et al.. (2011). Comparison of Physical Examination and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 4–6 Months After Radiotherapy to Assess Residual Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(5). e825–e832. 32 indexed citations
12.
Rosenthal, David I., Jonathan Harris, Arlene A. Forastiere, et al.. (2009). Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024. Journal of Clinical Oncology. 27(28). 4727–4732. 32 indexed citations
13.
Siker, Malika, et al.. (2009). Role of Radiation Therapy in Cutaneous Melanoma. Clinics in Plastic Surgery. 37(1). 147–160. 6 indexed citations
14.
Maheshwari, Mohit, Christopher J. Schultz, Michelle A. Michel, et al.. (2008). Clinical Outcomes of Patients Receiving Integrated PET/CT-Guided Radiotherapy for Head and Neck Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 70(3). 678–684. 71 indexed citations
15.
Spencer, Sharon A., Jonathan Harris, Richard Wheeler, et al.. (2007). Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head & Neck. 30(3). 281–288. 246 indexed citations
16.
Rosenthal, David I., Jay R. Harris, Arlene A. Forastiere, et al.. (2004). Early postoperative paclitaxel followed by paclitaxel and cisplatin concurrent with radiation therapy (RT) (phase II trial RTOG H-0024) is well tolerated for patients with resected, high-risk squamous carcinoma of the head and neck (HNSCC). International Journal of Radiation Oncology*Biology*Physics. 60(1). S322–S322. 2 indexed citations
17.
Chang, Chung‐Che, Bal Kampalath, Christopher J. Schultz, et al.. (2003). Expression of p53, c-Myc, or Bcl-6 Suggests a Poor Prognosis in Primary Central Nervous System Diffuse Large B-Cell Lymphoma Among Immunocompetent Individuals. Archives of Pathology & Laboratory Medicine. 127(2). 208–212. 50 indexed citations
18.
Corn, Benjamin W., Carol A. Dolinskas, Charles Scott, et al.. (2000). Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06. International Journal of Radiation Oncology*Biology*Physics. 47(2). 299–303. 17 indexed citations
19.
Campbell, Bruce H., David Mark, Emma Soneson, James E. Freije, & Christopher J. Schultz. (1997). The Role of Dental Prostheses in Alveolar Ridge Squamous Carcinomas. Archives of Otolaryngology - Head and Neck Surgery. 123(10). 1112–1115. 8 indexed citations
20.
Schultz, Christopher J., Charles Scott, William H. Sherman, et al.. (1996). Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.. Journal of Clinical Oncology. 14(2). 556–564. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne L. Wolden Breakdown of academic impact, for papers by Simon Krämer Breakdown of academic impact, for papers by Shiao Y. Woo Breakdown of academic impact, for papers by Tejpal Gupta Breakdown of academic impact, for papers by Luther W. Brady Breakdown of academic impact, for papers by Gerhard G. Grabenbauer Breakdown of academic impact, for papers by William F. Regine Breakdown of academic impact, for papers by Nancy P. Mendenhall Breakdown of academic impact, for papers by Marvin Rotman Breakdown of academic impact, for papers by Zhigang Zhang
Rankless by CCL
2026